New York, NY -- (SBWIRE) -- 12/21/2013 -- CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains. We’ve been improving our skills as traders and analysts for years, and we know – from experience – which indicators to look for. That’s why we’ve been able to choice some of the market’s biggest winners and send them to our followers before the rest of the market has any idea of what hit them. Here are some hot stocks to watch for:- Vical Incorporated(NASDAQ:VICL), Oramed Pharmaceuticals, Inc.(NASDAQ:ORMP), Delcath Systems, Inc.(NASDAQ:DCTH) , Cell Therapeutics Inc(NASDAQ:CTIC)
Vical Incorporated(NASDAQ:VICL) increased 5.77% and closed at $1.10 on a traded volume of 3.71M shares, in comparison to 9664825 shares of average trading volume. The company has a total market capitalization of $95.46M .
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Has VICL Found The Bottom and Ready To Move Up? Find Out Here
Oramed Pharmaceuticals, Inc.(NASDAQ:ORMP) surged 48.95% and closed at $10.65 on a traded volume of 3.60M shares, whereas its average trading volume is 51383 . The Intra-day range for the stock is $10.05 and $13.69.
Oramed Pharmaceuticals Inc. is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides.
For How Long ORMP Gloss will Attract Investors? Find out via this report
Delcath Systems, Inc.(NASDAQ:DCTH) surged 10.28% and closed at $0.265. The 52-week range for the stock is $0.22 and $2.19 and during the previous trading session the stock touched its highest price at $0.26. Its introductory price for the day was $0.24, with the overall traded volume of 3.48M shares.
Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver.
Will DCTH Continue To Move Higher? Find Out Here
Cell Therapeutics Inc(NASDAQ:CTIC) after opening its trade at the price of $1.77, gain 1.72% to close at $1.77 for the day. The stock moved on a traded volume of 4.08M shares, in comparison to 3.15M shares of average trading volume.The 52-week range for the stock is $0.97 and $2.17 and during the previous trading session the stock touched its highest price at $1.79.
Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer.
Why Should Investors Buy CTIC After The Recent Gain? Just Go Here and Find Out
CaddyStocks record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
The employees of CaddyStocks.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation; warranty or guaranty is made as to its accuracy or completeness. CaddyStocks.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither CaddyStocks.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by CaddyStocks.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Read Full Disclaimer at: http://caddystocks.com/disclaimer.html/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)